Manufactured for: Revised: November 2025 Vial Label - 1 mL: NDC 87188-111-01 Rx Only Cyanocobalamin Injection, USP 1,000 mcg/mL For Intramuscular or Subcutaneous Use Only 1 mL Multiple-Dose Vial Carton Label - 1 mL: NDC 87188-111-90 Rx Only Cyanocobalamin Injection, USP 1,000 mcg/mL For Intramuscular or Subcutaneous Use Only 25 X 1 mL Multiple-Dose Vials Vial Label - 10 mL: NDC 87188-112-01 Rx Only Cyanocobalamin Injection, USP 10,000 mcg/10 mL (1,000 mcg/mL) For Intramuscular or Subcutaneous Use Only 10 mL Multiple-Dose Vial Carton Label - 10 mL: NDC 87188-112-01 Rx Only Cyanocobalamin Injection, USP 10,000 mcg/10 mL (1,000 mcg/mL) For Intramuscular or Subcutaneous Use Only 1 x 10 mL Multiple-Dose Vial Vial Label - 30 mL: NDC 87188-113-01 Rx Only Cyanocobalamin Injection, USP 30,000 mcg/30 mL (1,000 mcg/mL) For Intramuscular or Subcutaneous Use Only 30 mL Multiple-Dose Vial Carton Label - 30 mL: NDC 87188-113-01 Rx Only Cyanocobalamin Injection, USP 30,000 mcg/30 mL (1,000 mcg/mL) For Intramuscular or Subcutaneous Use Only 1 x 30 mL Multiple-Dose Vial
1.1.5 HIV and Hepatitis Oxidative Stress has always played a major pathogenic role in HIV and hepatitis infections
Why There Isn't a Universal Protocol BPC-157 doesn't have an FDA-reviewed protocol
Most studies involve small participant numbers, short follow-up periods, and lack robust placebo controls, limiting the strength of conclusions
Compound-level research most associates the GLOW combination with soft-tissue repair coverage, collagen and skin-quality remodeling driven by GHK-Cu, anti-inflammatory pathway overlap, and organized matrix formation
BrownALLaneJCoverlyJStocksJJacksonSStephenAet al
